US20060020113A9 - Serpentine transmembrane antigens expressed in human cancers and uses thereof - Google Patents

Serpentine transmembrane antigens expressed in human cancers and uses thereof Download PDF

Info

Publication number
US20060020113A9
US20060020113A9 US10/753,195 US75319504A US2006020113A9 US 20060020113 A9 US20060020113 A9 US 20060020113A9 US 75319504 A US75319504 A US 75319504A US 2006020113 A9 US2006020113 A9 US 2006020113A9
Authority
US
United States
Prior art keywords
steap
protein
antibody
cells
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10/753,195
Other versions
US7947459B2 (en
US20050004349A1 (en
Inventor
Rene Hubert
Arthur Raitano
Douglas Saffran
Daniel Afar
Steven Mitchell
Mary Faris
Aya Jakobovits
Original Assignee
Hubert Rene S
Raitano Arthur B
Douglas Saffran
Afar Daniel E H
Mitchell Steven C
Mary Faris
Aya Jakobovits
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US8752098P priority Critical
Priority to US9118398P priority
Priority to US09/323,873 priority patent/US6329503B1/en
Priority to US09/455,486 priority patent/US6833438B1/en
Priority to PCT/US2000/033040 priority patent/WO2001040276A2/en
Priority to WOPCT/US00/33040 priority
Priority to US29665601P priority
Priority to US10/165,044 priority patent/US20030149531A1/en
Priority to US10/753,195 priority patent/US7947459B2/en
Application filed by Hubert Rene S, Raitano Arthur B, Douglas Saffran, Afar Daniel E H, Mitchell Steven C, Mary Faris, Aya Jakobovits filed Critical Hubert Rene S
Publication of US20050004349A1 publication Critical patent/US20050004349A1/en
Publication of US20060020113A9 publication Critical patent/US20060020113A9/en
Application granted granted Critical
Publication of US7947459B2 publication Critical patent/US7947459B2/en
Application status is Active legal-status Critical
Adjusted expiration legal-status Critical

Links